Reply:

Authors

  • Patrick R. Harrington Ph.D.,

    1. Division of Antiviral Products, Office of Antimicrobial Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
    Search for more papers by this author
  • Lisa K. Naeger Ph.D.,

    1. Division of Antiviral Products, Office of Antimicrobial Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
    Search for more papers by this author
  • Wen Zeng Ph.D.

    1. Division of Biometrics IV, Office of Biometrics, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
    Search for more papers by this author

  • Potential conflict of interest: Nothing to report.

  • The views expressed in this report are those of the authors and do not necessarily represent official policy of the U.S. Food and Drug Administration.

No abstract is available for this article.

Ancillary